Column Capital Advisors, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Column Capital Advisors, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$14,000
-44.0%
7500.0%0.00%
-40.0%
Q3 2021$25,000
-13.8%
7500.0%0.01%
-16.7%
Q2 2021$29,000
-19.4%
7500.0%0.01%
-25.0%
Q1 2021$36,000
-7.7%
7500.0%0.01%
-20.0%
Q4 2020$39,000
+95.0%
7500.0%0.01%
+66.7%
Q3 2020$20,000
+42.9%
7500.0%0.01%
+20.0%
Q2 2020$14,000
+27.3%
750
-33.3%
0.01%
+25.0%
Q1 2020$11,000
+37.5%
1,124
+49.9%
0.00%0.0%
Q4 2019$8,0007500.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders